Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Archives of General Psychiatry
|
December 1, 1992
Negative symptoms and hypofrontality in chronic schizophrenia
A Wolkin, M Sanfilipo, A P Wolf, et al.
Journal of Clinical Psychopharmacology
|
October 1, 1986
The dexamethasone suppression test and response to placebo
E D Peselow, A Lautin, A Wolkin, et al.
Biological Psychiatry
|
October 15, 1993
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics
E Duncan, A Wolkin, B Angrist, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1983
Plasma cortisol values after dexamethasone in depressed inpatients
E D Peselow, M Serby, A Wolkin, et al.
Psychopharmacology
|
January 1, 1987
Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography
A Wolkin, B Angrist, A Wolf, et al.
Psychiatry Research
|
October 1, 1991
Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia
E J Bartlett, A Wolkin, J D Brodie, et al.
Psychiatry Research
|
May 1, 1991
Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia
E J Bartlett, F Barouche, J D Brodie, et al.
Life Sciences
|
December 27, 1982
Red cell phospholipids in schizophrenia
A Lautin, D M Cordasco, D J Segarnick, et al.
The American Journal of Psychiatry
|
February 1, 1988
Low frontal glucose utilization in chronic schizophrenia: a replication study
A Wolkin, B Angrist, A Wolf, et al.
Archives of General Psychiatry
|
May 12, 2000
Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms
M Sanfilipo, T Lafargue, H Rusinek, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Archives of General Psychiatry
|
December 1, 1992
Negative symptoms and hypofrontality in chronic schizophrenia
A Wolkin, M Sanfilipo, A P Wolf, et al.
Journal of Clinical Psychopharmacology
|
October 1, 1986
The dexamethasone suppression test and response to placebo
E D Peselow, A Lautin, A Wolkin, et al.
Biological Psychiatry
|
October 15, 1993
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics
E Duncan, A Wolkin, B Angrist, et al.
Journal of Clinical Psychopharmacology
|
February 1, 1983
Plasma cortisol values after dexamethasone in depressed inpatients
E D Peselow, M Serby, A Wolkin, et al.
Psychopharmacology
|
January 1, 1987
Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography
A Wolkin, B Angrist, A Wolf, et al.
Psychiatry Research
|
October 1, 1991
Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia
E J Bartlett, A Wolkin, J D Brodie, et al.
Psychiatry Research
|
May 1, 1991
Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia
E J Bartlett, F Barouche, J D Brodie, et al.
Life Sciences
|
December 27, 1982
Red cell phospholipids in schizophrenia
A Lautin, D M Cordasco, D J Segarnick, et al.
The American Journal of Psychiatry
|
February 1, 1988
Low frontal glucose utilization in chronic schizophrenia: a replication study
A Wolkin, B Angrist, A Wolf, et al.
Archives of General Psychiatry
|
May 12, 2000
Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms
M Sanfilipo, T Lafargue, H Rusinek, et al.
Page
of 4